Ratification Date: 21/07/2025

Next Review Date: 21/07/2027

Epoprostenol (prostacyclin – Flolan) – Primary pulmonary hypertension – as per NHS England policy – specialist centre only

Drug Name (Brand) Epoprostenol (prostacyclin) ▼  (Flolan®)
Indication Primary pulmonary hypertension – as per NHS England policy – specialist centre only
Traffic Light Classification Red
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

Sepetmber 2011:

The TAG noted the National Specialised Commissioning Group (NCG) Interim Commissioning Policy (July 2008) on Target therapies for the treatment of pulmonary arterial hypertension in adults.

 

Only centres designated by the NCG may provide pulmonary hypertension services for adults are able to initiate treatment.

 

April 2013: NHS England SCG took over commissioning responsibility for this treatment.

 

Date of TAG recommendation / ratification 9/1/2011